Amrize Ltd AMRZ
38.22
0.99
2.66%
as of 25 Sep
- Market cap
- $20.5B
- P/E
- 17.5×
Follow AMRZ
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | |
|---|---|---|---|
P/E ratio |
25.12 | 20.01 | 20.01 |
P/S ratio |
2.53 | 0.00 | 0.00 |
P/FCF ratio |
20.47 | 43.05 | 43.05 |
P/Operating CF |
16.58 | (33.59) | (33.59) |
P/B ratio |
2.28 | 2.90 | 2.90 |
Price to Tangible BV |
12.73 | 2.90 | 2.90 |
EV/Sales |
2.82 | 0.00 | 0.00 |
EV/EBITDA |
11.79 | 0.00 | 0.00 |
EV/Operating CF |
15.06 | 19.84 | 19.84 |
EV/FCF |
22.76 | 42.34 | 42.34 |
Quick Ratio |
1.06 | 1.25 | 1.03 |
Current Ratio |
1.64 | 1.87 | 1.61 |
Net Debt/EBITDA |
1.19 | (0.16) | 0.00 |
Debt/Assets |
21.73% | 4.68% | 4.80% |
Debt/Equity |
0.40 | 0.11 | 0.12 |
Asset Turnover |
0.49 | 0.50 | 0.00 |
Operating CF/Net income |
1.86 | 1.79 | 2.13 |
Capex/Depreciation |
(0.82) | (0.62) | (0.68) |
Interest Coverage |
0.00 | 0.00 | 0.00 |
| 10.23% | 13.33% | 0.00% | |
| 4.93% | 5.44% | 0.00% | |
ROIC |
7.18% | 14.07% | 12.71% |
Return on Tangible Assets |
12.14% | 13.05% | 10.49% |
Average Days of Receivables |
34.60 | 49.93 | 43.70 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
9.55% | 8.07% | 7.69% |
Intangible Assets out of Total Assets |
0.44 | 0.45 | 0.47 |
Share Based Compensation of Revenue |
0.12% | 0.05% | 0.04% |
Graham Net Nets |
(0.22) | 0.17 | 0.17 |
Graham Number |
33.90 | 0.00 | 0.00 |
Earnings Yield |
3.98% | 5.00% | 5.00% |
Free Cash Flow Yield |
4.88% | 2.32% | 2.32% |
Revenue per Share |
21.36 | 21.16 | 0.00 |
Operating CF per Share |
3.99 | 4.13 | 0.00 |
Capex per Share |
(1.35) | (0.99) | 0.00 |
Free Cash Flow per Share |
2.64 | 3.13 | 0.00 |
Cash per Share |
3.48 | 2.87 | 0.00 |
Shareholders Equity per Share |
23.96 | 17.92 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
23.96 | 17.92 | 0.00 |
Free Cash Flow |
1,461.00 | 1,733.00 | 1,455.00 |
Working Capital |
1,824.00 | 2,231.00 | 1,496.00 |
Capital Expenditures |
(747.00) | (549.00) | (581.00) |
Net Current Asset Value |
(6,314.00) | (9,110.00) | (9,905.00) |
EV/EBIT |
17.45 | 0.00 | 0.00 |
Capex to Sales |
0.06 | 0.05 | 0.05 |
Net Profit Margin |
10.03% | 10.89% | 8.19% |
Price to Operating Income |
15.69 | 0.00 | 0.00 |
| Other line items | |||
Depreciation/Fixed assets |
0.12 | 0.12 | 0.11 |
Cash ROIC |
(28.01%) | (41.64%) | (48.91%) |
Accounts Receivable Turnover |
8.68 | 7.81 | 0.00 |
Accounts Payable Turnover |
6.22 | 6.82 | 0.00 |
Inventory Turnover |
5.85 | 6.26 | 0.00 |
Average Days of Payables |
63.93 | 54.32 | 51.14 |
Days of Inventory on Hand |
64.47 | 61.38 | 53.55 |
Average Receivables |
1,360.50 | 1,499.50 | — |
Average Payables |
1,411.50 | 1,266.50 | — |
Average Inventory |
1,501.50 | 1,379.50 | — |
Average Assets |
24,027.00 | 23,426.00 | — |
Average Common Equity |
11,584.00 | 9,558.50 | — |
Columns are period end dates